REG - Barr(A.G.) PLC - Interim Results
24/09/2024 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240924:nRSX3255Fa&default-theme=true
RNS Number : 3255F Barr(A.G.) PLC 24 September 2024
IMMEDIATE RELEASE
24 September 2024
A.G. BARR p.l.c.
("A.G. BARR")
A.G. BARR p.l.c., the branded multi-beverage business with a portfolio of
market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and Boost.
INTERIM RESULTS FOR THE 26 WEEKS ENDED 27 JULY 2024
Strong H1 growth in revenue and operating profit, with operating margin
expansion, underpins delivery of full year expectations
Financial summary
26 wks to 27 July 2024 26 wks to 30 July 2023 Change
Revenue £221.3m £210.4m 5.2%
Profit before tax (adjusted)* £29.3m £27.0m 8.5%
Operating margin (adjusted)* 13.0% 12.5% 50 bps
Profit before tax £24.9m £27.8m (10.4%)
Basic EPS 16.88p 18.87p (10.5%)
Basic EPS (adjusted)* 19.86p 18.15p 9.4%
Interim dividend per share 3.10p 2.65p 17.0%
Net cash at bank* £43.7m £47.3m (7.6%)
* Items marked with an asterisk are non-GAAP measures. Definitions and
relevant reconciliations are provided at the end of this announcement
Highlights
○ Total revenue growth of 5.2%, driven by Soft Drinks up 7.0%, with
Rubicon and IRN-BRU delivering both volume and price gains
○ A strong H1 profit performance from successfully executing a clear
and consistent strategy. Profit before tax (adjusted)* up 8.5%
○ Profit before tax of £24.9m is after £4.4m of one-off costs
related to the closure of Barr Direct and the integration of Boost
○ Operating margin (adjusted)* up 50 bps demonstrating further
progress with the margin rebuild programme, with continued benefit anticipated
in H2
○ Net cash at bank* of £43.7m, down from £47.3m due to successful
acquisition of Rio in October 23, along with significant availability on
committed debt facilities to support future growth
○ Interim dividend of 3.10 pence per share representing an increase on
the prior year of 17.0%
Euan Sutherland, Chief Executive, commented:
"My first few months with the business has further cemented my view that AG
Barr is an excellent business with exciting, tangible and deliverable growth
opportunities. I am pleased to report a strong set of first half results.
The business has delivered both revenue and profit growth as well as good
progress on our key strategic margin rebuild programme.
We continue to invest in our supply chain to build the capacity to support our
growth plans and manufacture more volume in-house. This will deliver
tangible benefits including enhanced margin and improved service resilience.
We anticipate a strong H2 performance from our four core brands - IRN-BRU,
Rubicon, Boost and FUNKIN - in particular, with current trading momentum
underpinned by further marketing and innovation activities.
Guidance on 2024/25 revenue and operating margin is unchanged. We remain
confident of continued, sustainable growth over the long term, in line with
our strategic ambitions."
For more information, please contact:
A.G. BARR 0330 390
3900
Instinctif Partners 020 7457 2020
Euan Sutherland, Chief
Executive
Justine Warren
Stuart Lorimer, Finance
Director
Matthew Smallwood
_______________________________________________________________________________
Interim statement
We are pleased to report a strong H1 performance through execution of our
clear and consistent growth strategy of building brands that people love.
Revenue increased 5.2% to £221.3m and operating margin (adjusted)* improved
by 50 bps to 13.0%. This delivered profit before tax (adjusted)* growth of
8.5% to £29.3m.
Particularly pleasing was the performance of our Soft Drinks business where
revenue increased 7.0%, driven by both volume and price. Rubicon was the
stand out performer, delivering double digit growth in both volume and value.
Profit before tax of £24.9m included a non-recurring (£4.4m) adjusting item
related to the business change projects involving the closure of Barr Direct
and the integration of the Boost business.
These key projects progressed to plan in H1. The Barr Direct route to market
closed at the end of June with no impact to customer service. Symbol and
Independent retailers are now fully serviced through the wholesale route to
market, supported by a larger in-house Field Sales team. The integration of
the Boost business, acquired in 2022, is on track and will be completed during
H2. Our expectation of the payback from these two projects remains less than
2 years. Manufacturing synergies continue to be realised as production is
insourced in line with our plan.
Market context
Soft drinks:
The UK soft drinks market was up 2.0% versus the same period in the prior
year. Growth was price led with volumes marginally down (0.4%), partly as a
consequence of the disappointing early summer weather. Whilst value was up,
the level of price inflation in the market has reduced significantly versus
the peak in 2023. Overall, our performance was ahead of the market across
both volume and value, with growth primarily arising in segments not measured
by market analytic data.
(Source : Circana data for the 26 weeks to 27 July 2024)
Cocktails:
Ready to drink (RTD) cocktails in the take home market grew 9.1%, well ahead
of the wider pre-mixed alcoholic drinks market growth rate of 2.7%. FUNKIN's
growth was ahead of both market segments and it remains the number one brand
in the RTD cocktail market.
As has been widely documented, the UK on-trade market continued to experience
challenging trading conditions during the period. The value of cocktails in
the on-trade declined by (1.3%) in the year to March 2024 driven primarily by
a (1.9%) reduction in the number of outlets. Cocktails performed relatively
favourably within this wider trend, marginally growing volume share. Whilst
we expect on-trade cocktail consumption to return to growth in the longer
term, this may take some time given current economic and consumer trends.
(Source: Nielsen pre-mixed alcoholic drinks total coverage YTD 13/07/2024; CGA
Q1 2024)
Business performance
Overall revenue growth of 5.2% driven by Soft drinks performance.
Revenue Change vs
(£m) H1 2023/24 (%)
Soft drinks £194.6m 7.0%
Cocktail solutions (FUNKIN) £21.1m (9.4%)
Other (MOMA) £5.6m 7.7%
7.0% growth in Soft Drinks revenue was led by Rubicon, which continued to grow
ahead of the market through distribution gains and an increase in marketing
investment. Revenue from IRN-BRU was up through a combination of volume and
value growth, with a highly effective Euros marketing campaign and continued
market share gains in England. The focus for Boost this year is on margin
improvement, including profit recovery and insourcing of production. This is
progressing in line with plan. Our soft drinks business carried good
momentum into H2 and we expect further growth in the second half supported by
our promotional and marketing investment plans.
FUNKIN experienced a challenging H1 with revenue down (9.4%). The key driver
of this decline was on-going weak consumer demand in the on-trade channel
where late night venues remained particularly affected. More positively, the
FUNKIN ready-to-drink (RTD) business has continued to grow at pace in the
strategic growth channel of retail despite revenue in H1 being impacted by a
short term issue with third party can production which impacted sales to
retailers but is now resolved. With a more resilient supply chain now in
place and an exciting innovation pipeline we expect FUNKIN to perform
positively in H2.
MOMA maintained its growth in H1 with new distribution gains. We expect
MOMA's growth to accelerate in H2 through further range development.
Cash flow and balance sheet
Net cash from operating activities of £13.0m was £2.1m below the prior year
(2023/24 H1: £15.1m). This was primarily driven by the non-recurring
costs associated with the business change projects.
We have managed working capital effectively across H1. We collected cash in
a timely manner from our customers and had no significant unrecoverable debt
during the period. Inventory levels have generally been good albeit we
experienced a small number of specific issues with third party suppliers which
temporarily reduced inventory below desired levels and are now resolved.
Capital expenditure* in H1 was £7.4m (2023/24 H1: £6.5m). As in the
prior year, our plan sees higher capital expenditure expected in the second
half of the year due to the timing of specific activities. During H1 the key
project completed was the installation and commissioning of a new small PET
line in Cumbernauld, which provides increased manufacturing capability and
resilience for the long term. The Cumbernauld factory asset refresh
programme remains on track, and is expected to be completed by January 2026.
Full year capital expenditure* in the current year is estimated at c.£20m
(2023/24: £17.8m), with H2 expenditure concentrated on investment in
Cumbernauld and Milton Keynes manufacturing lines.
The business closed the period with net cash at bank* of £43.7m. This was
£3.6m lower than the Interim reporting date in the prior year, principally
owing to the £12.3m cash outflow in acquiring Rio in October 2023. The
closing net cash at bank* balance was £9.9m less than the period opening
position (£53.6m) due to the normal funding of dividend, tax and capital
expenditure, alongside the seasonal demands for higher working capital during
the summer trading period. We expect our cash balance to increase in H2 as
it has historically.
Board
As previously communicated, after 20 years, Jonathan Kemp stepped down from
the Board in May and will retire from his position as Commercial Director at
the end of September 2024. Jonathan will remain with the company until
September 2025 to lead a number of projects and support a smooth transition.
We are pleased to announce the appointment of Dino Labbate. Dino joins in
January 2025 from Britvic, in a newly created, broader role of MD A.G. BARR,
reporting to the CEO.
The transition of CEO is now complete and has been executed successfully
without any disruption to the business. Looking forward, the senior
leadership team is fully focused on delivering the business' strategy and
accelerating its growth trajectory.
Dividend
The Board has declared an interim dividend for the 26 weeks ended 27 July 2024
of 3.10 pence per share (2023/24: 2.65 pence) payable on 1 November 2024 to
shareholders on the register on 4 October 2024. This is in line with our
policy of the interim dividend being 25% of the prior final year dividend.
Outlook
The positive H1 performance was in line with our expectations and we have
ambitious plans for H2 and beyond, which are consistent with our long term
growth strategy. We will continue to invest behind our brands to drive
revenue growth, and continue to progress our strategic project agenda to
deliver margin improvement and strengthen our supply base. We remain
conscious of the current pressure on consumers and will be responsive to
changes in the dynamic markets in which we operate. We are confident that,
assuming a reasonably settled external environment, the execution of our plans
will result in a strong H2 and the delivery of a full year performance in line
with current market expectations**.
Mark
Allen
Euan Sutherland
Chairman
Chief Executive
** Analyst consensus: FY24/25 Net Revenue £421.5m, PBT £57.2m (FY23/24 PBT
£50.5m)
Consolidated Condensed Income Statement
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
Note £m £m £m
Revenue 6 221.3 210.4 400.0
Cost of sales (132.2) (131.0) (245.8)
Gross profit 6 89.1 79.4 154.2
Operating expenses (64.8) (52.2) (104.1)
Operating profit 8 24.3 27.2 50.1
Finance income 9 0.8 0.7 1.4
Finance costs 9 (0.2) (0.1) (0.2)
Profit before tax 24.9 27.8 51.3
Tax on profit 10 (6.2) (6.8) (12.8)
Profit attributable to equity holders 18.7 21.0 38.5
Earnings per share (pence)
Basic earnings per share 11 16.88 18.87 34.59
Diluted earnings per share 11 16.72 18.67 34.24
Consolidated Condensed Statement of Financial Position
Unaudited Unaudited Audited
As at 27 July 2024 As at 30 July 2023 As at 28 January 2024
Note £m £m £m
Non-current assets
Intangible assets 129.9 115.6 130.4
Property, plant and equipment 107.8 102.2 109.0
Right-of-use assets 4.6 5.2 5.2
Retirement benefit surplus 17 6.2 3.2 3.2
248.5 226.2 247.8
Current assets
Inventories 35.6 36.0 36.5
Trade and other receivables 94.1 93.9 63.8
Assets classified as held for sale 13 2.1 - -
Current tax asset 0.2 - -
Short-term investments 32.5 - 20.0
Cash and cash equivalents 17.3 47.3 33.6
181.8 177.2 153.9
Total assets 430.3 403.4 401.7
Current liabilities
Loans and other borrowings 15 6.1 - -
Trade and other payables 86.9 90.7 70.3
Derivative financial instruments 14 0.5 0.3 0.3
Lease liabilities 14 1.7 1.6 1.8
Provisions 16 2.0 0.5 0.5
Current tax liabilities - 0.9 0.7
97.2 94.0 73.6
Non-current liabilities
Deferred tax liabilities 33.0 28.8 32.3
Lease liabilities 14 2.6 3.2 3.1
Derivative financial instruments 14 0.1 - -
35.7 32.0 35.4
Capital and reserves
Share capital 4.7 4.7 4.7
Share premium account 0.9 0.9 0.9
Share options reserve 3.1 4.0 4.0
Other reserves (0.5) (0.1) (0.1)
Retained earnings 289.2 267.9 283.2
297.4 277.4 292.7
Total equity and liabilities 430.3 403.4 401.7
Consolidated Condensed Statement of Comprehensive Income
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
£m £m £m
Profit for the period 18.7 21.0 38.5
Other comprehensive (expense)/income
Items that will not be reclassified to profit or loss
Remeasurements on defined benefit pension plans (Note 17) - 0.7 0.7
Deferred tax movements on items above - (0.2) (0.2)
Items that will be or have been reclassified to profit or loss
Loss arising on cash flow hedges during the period (0.6) (0.3) (0.3)
Deferred tax movements on items above 0.2 0.1 0.1
Other comprehensive (expense)/income for the period, net of tax (0.4) 0.3 0.3
Total comprehensive income attributable to equity holders of the parent 18.3 21.3 38.8
Consolidated Condensed Statement of Changes in Equity (Unaudited)
Share capital Share premium account Share options reserve Other reserves Retained earnings Total
£m £m £m £m £m £m
At 28 January 2024 4.7 0.9 4.0 (0.1) 283.2 292.7
Profit for the period - - - - 18.7 18.7
Other comprehensive expense - - - (0.4) - (0.4)
Total comprehensive (expense)/income for the period - - - (0.4) 18.7 18.3
Company shares purchased for use by employee benefit trusts - - - - (1.9) (1.9)
Proceeds on disposal of shares by employee benefit trusts - - - - 0.7 0.7
Recognition of share-based payment costs - - 1.4 - - 1.4
Transfer of reserve on share award - - (2.3) - 2.3 -
Dividends paid - - - - (13.8) (13.8)
At 27 July 2024 4.7 0.9 3.1 (0.5) 289.2 297.4
Share capital Share premium account Share options reserve Other reserves Retained earnings Total
£m £m £m £m £m £m
At 29 January 2023 4.7 0.9 3.4 0.1 259.7 268.8
Profit for the period - - - - 21.0 21.0
Other comprehensive (expense)/income - - - (0.2) 0.5 0.3
Total comprehensive (expense)/income for the period - - - (0.2) 21.5 21.3
Company shares purchased for use by employee benefit trusts - - - - (2.6) (2.6)
Proceeds on disposal of shares by employee benefit trusts - - - - 0.8 0.8
Recognition of share-based payment costs - - 1.0 - - 1.0
Transfer of reserve on share award - - (0.3) - 0.3 -
Deferred tax on items taken direct to reserves - - (0.1) - - (0.1)
Dividends paid - - - - (11.8) (11.8)
At 30 July 2023 4.7 0.9 4.0 (0.1) 267.9 277.4
Consolidated Condensed Statement of Changes in Equity (Audited)
Share capital Share premium account Share options reserve Other reserves Retained earnings Total
£m £m £m £m £m £m
At 29 January 2023 4.7 0.9 3.4 0.1 259.7 268.8
Profit for the year - - - - 38.5 38.5
Other comprehensive (expense)/income - - - (0.2) 0.5 0.3
Total comprehensive (expense)/income for the year - - - (0.2) 39.0 38.8
Company shares purchased for use by employee benefit trusts - - - - (3.6) (3.6)
Proceeds on disposal of shares by employee benefit trusts - - - - 1.3 1.3
Recognition of share-based payment costs - - 2.1 - - 2.1
Transfer of reserve on share award - - (1.6) - 1.5 (0.1)
Deferred tax on items taken direct to reserves - - 0.1 - - 0.1
Dividends paid - - - - (14.7) (14.7)
At 28 January 2024 4.7 0.9 4.0 (0.1) 283.2 292.7
Consolidated Condensed Cash Flow Statement
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
£m £m £m
Operating activities
Profit for the period before tax 24.9 27.8 51.3
Adjustments for:
Interest receivable (0.8) (0.7) (1.4)
Interest payable 0.2 0.1 0.2
Impairment of investment in associate - 0.7 0.7
Write off of loans and receivables - 1.5 1.5
Contingent consideration - (0.8) (0.8)
Depreciation of property, plant and equipment 5.8 5.4 11.2
Amortisation of intangible assets 0.5 0.6 1.1
Share-based payment costs 1.4 1.0 2.1
Impairment of assets classified as held for sale 1.1 - -
(Gain)/loss on sale of property, plant and equipment (0.1) 0.1 (0.5)
Operating cash flows before movements in working capital 33.0 35.7 65.4
Decrease/(increase) in inventories 0.9 (1.3) (1.8)
Increase in receivables (30.3) (33.5) (3.4)
Increase in payables 18.5 20.4 -
Difference between employer pension contributions and amounts recognised in (2.9) - -
the income statement
Cash generated by operations 19.2 21.3 60.2
Tax paid (6.2) (6.2) (11.7)
Net cash from operating activities 13.0 15.1 48.5
Investing activities
Acquisition of subsidiary - - (12.3)
Purchase of property, plant and equipment (7.4) (6.5) (17.8)
Proceeds on sale of property, plant and equipment 0.2 - 0.6
Funds placed on fixed term deposit (37.5) (25.0) (20.0)
Funds returned from fixed term deposit 25.0 65.0 40.0
Interest received 0.5 1.1 1.4
Net cash used in investing activities (19.2) 34.6 (8.1)
Financing activities
Loans made - 5.0 5.0
Loans repaid - (5.7) (5.7)
Lease payments (1.1) (1.0) (1.9)
Purchase of Company shares by employee benefit trusts (1.9) (2.6) (3.6)
Proceeds from disposal of Company shares by employee benefit trusts 0.7 0.8 1.3
Dividends paid (13.8) (11.8) (14.7)
Interest paid (0.1) - (0.1)
Net cash used in financing activities (16.2) (15.3) (19.7)
Net (decrease)/increase in cash and cash equivalents (22.4) 34.4 20.7
Cash and cash equivalents at beginning of period 33.6 12.9 12.9
Cash and cash equivalents at end of period 11.2 47.3 33.6
Cash and cash equivalents per the cash flow statement comprises cash and cash
equivalents per the statement of financial position of £17.3m, net of bank
overdrafts of £6.1m for the period ended 27 July 2024.
Notes to the Consolidated Condensed Financial Statements
1. General information
A.G. BARR p.l.c. (the "Company") and its subsidiaries (together the "Group")
manufacture, distribute and sell a range of beverages. The Group has
manufacturing sites in the UK and sells mainly to customers in the UK with
some international sales.
The Company is a public limited company, which is listed on the London Stock
Exchange and incorporated and domiciled in Scotland. The address of its
registered office is Westfield House, 4 Mollins Road, Cumbernauld, G68 9HD.
This consolidated condensed interim financial information does not comprise
statutory accounts within the meaning of section 434 of the Companies Act
2006. Statutory accounts for the year ended 28 January 2024 were approved by
the Board of Directors on 26 March 2024 and delivered to the Registrar of
Companies. The comparative figures for the financial year ended 28 January
2024 are an extract of the Company's statutory accounts for that year. The
report of the auditor on those accounts was unqualified, did not contain an
emphasis of matter paragraph and did not contain any statement under section
498 (2) or (3) of the Companies Act 2006.
This consolidated condensed interim financial information is unaudited but has
been reviewed by the Company's Auditor.
2. Basis of preparation
This consolidated condensed interim financial information for the 26 weeks
ended 27 July 2024 has been prepared in accordance with UK-adopted
International Accounting Standard 34, 'Interim Financial Reporting' and the
Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's
Financial Conduct Authority. The interim report does not include all of the
notes of the type normally included in an annual financial report.
Accordingly, this report is to be read in conjunction with the annual report
for the year ended 28 January 2024, which has been prepared in accordance with
UK-adopted international accounting standards and with the requirements of the
Companies Act 2006.
Going concern basis
The directors have adopted the going concern basis in preparing these accounts
after assessing the principal risks.
There has been no further update to the assessment undertaken in the year
ended 28 January 2024, which remains valid. This reviewed a number of severe
but plausible downside scenarios that could impact the business (both
individually and cumulatively) over the period until January 2027. These
scenarios include a major brand issue which impacts reputation and consumer
purchasing, a cyber attack and a global pandemic. In each scenario the Group
continues to be cash generative throughout the forecast horizon, resulting in
our liquidity headroom being maintained.
Our experience through the Covid-19 pandemic has given us confidence that the
Group can remain profitable and cash generative through prolonged disruption.
The most significant potential financial impact would be due to a significant
reduction in sales. The revenue and operational leverage impact of such a
volume loss would have a negative impact on Group profitability, however the
scenario modelling would indicate that the Group would remain profitable over
the next 12 months and we would anticipate a recovery in the following years.
The Group has £20m of committed, unutilised revolving credit facilities
providing the business with a secure funding platform. The facility expires in
February 2026. In the period, the Group has put in place a £15m overdraft
facility to support intra-month working capital requirements and maximise cash
deposit interest. Throughout these severe but plausible downside scenarios,
the Group continues to have significant liquidity headroom on existing
facilities and against the revolving credit facilities financial covenants.
The directors believe that the Group is well placed to manage its financing
and other business risks satisfactorily, and have a reasonable expectation
that the Group and parent Company will have adequate resources to continue in
operation for at least 12 months from the signing date of these condensed
consolidated financial statements. They therefore consider it appropriate to
adopt the going concern basis of accounting in preparing these financial
statements.
3. Accounting policies
New standards and interpretations applied for the first time
In the current year, the Group has applied a number of amendments to IFRS
Accounting Standards issued by the International Accounting Standards Board
(IASB) and endorsed for use in the UK which are mandatorily effective for
accounting periods beginning on or after 29 January 2024. Apart from those
changes to accounting policies noted below, the accounting policies applied in
these condensed interim financial statements are the same as those applied in
the most recent annual report for the year ended 28 January 2024. There has
been no material impact on the amounts reported or disclosures required in
these condensed interim financial statements.
- Classification of Liabilities as Current or Non-current and Non-current
liabilities with covenants - Amendments to IAS 1
- Lease liability in sale and leaseback - Amendments to IFRS 16
- Supplier Finance Arrangements - Amendments to IAS 7 and IFRS 7
Assets classified as held for sale
Assets classified as held for sale are measured at the lower of the carrying
amount and fair value less costs to sell where the assets meet the 'held for
sale' criteria within IFRS 5. Depreciation on these assets ceases and they are
presented within current assets in the balance sheet.
4. Principal risks and uncertainties
The directors consider that the following principal risks and uncertainties
could have a material impact on the Group's performance in the balance of the
financial year. Further detail can be found on pages 48 - 55 of the Group's
annual financial statements as at 28 January 2024, which are available on our
website, www.agbarr.co.uk.
- Changes in consumer preferences, perception or purchasing behaviour
- Consumer rejection of reformulated products
- Loss of product integrity
- Loss of continuity of supply of major raw materials
- Adverse publicity in relation to the soft drinks industry, the Group or its
brands
- Government intervention on climate change and environmental issues e.g.
packaging waste
- Failure to maintain customer relationships or take account of changing
market dynamics
- Inability to protect the Group's intellectual property rights
- Failure of the Group's operational infrastructure
- Failure of critical IT systems or a breach of cyber security
- Financial risks
- Environmental Social and Governance (ESG) risks
The Group has reviewed its exposure to climate-related and other emerging
business risks but has not identified any specific risks that would impact the
financial performance or position of the Group at 27 July 2024.
5. Financial risk management and financial instruments
The Group's activities expose it to a variety of financial risks: market risk
(including foreign exchange risk, cash flow and fair value interest rate risk
and price risk), credit risk and liquidity risk.
The condensed interim financial statements should be read in conjunction with
the Group's annual financial statements as at 28 January 2024 as they do not
include all financial risk management information and disclosures contained
within the annual financial statements. There have been no changes in the risk
management policies since the year end.
6. Segment reporting
The Board and senior executives have been identified as the Group's chief
operating decision-makers, who review the Group's internal reporting in order
to assess performance and allocate resources.
The performance of the operating segments is assessed by reference to their
gross profit.
Unaudited
Six months ended 27 July 2024
Soft drinks Cocktail solutions Other Total
£m £m £m £m
Total revenue 194.6 21.1 5.6 221.3
Gross profit 79.5 7.8 1.8 89.1
Unaudited
Six months ended 30 July 2023
Soft drinks Cocktail solutions Other Total
£m £m £m £m
Total revenue 181.9 23.3 5.2 210.4
Gross profit 69.9 7.9 1.6 79.4
Audited
Year ended 28 January 2024
Soft drinks Cocktail solutions Other Total
£m £m £m £m
Total revenue 346.6 42.9 10.5 400.0
Gross profit 135.6 15.4 3.2 154.2
There are no material intersegment sales. All revenue is in relation to
product sales, which is recognised at a point in time, upon delivery to the
customer.
All of the assets and liabilities of the Group are managed on a central basis
rather than at a segment level. As a result, no reconciliations of segment
assets and liabilities to the consolidated condensed statement of financial
position has been disclosed for any of the periods presented.
Included in revenues arising from the above segments are revenues of
approximately £39.0m which arose from sales to the Group's largest customer.
In the year ended 28 January 2024 and six months ended 30 July 2023, revenues
of approximately £68.0m and £37.5m respectively arose from sales to the
Group's largest customer. No other single customer contributed 10 per cent or
more to the Group's revenue in the comparative period to July 2023 or January
2024.
All of the segments included within "Soft drinks" and "Cocktail solutions"
meet the aggregation criteria set out in IFRS 8 Operating Segments.
7. Seasonality of operations
Revenues and reported profits are affected by weather conditions, cost
inflation, the timing of marketing and promotional investment and innovation
launches. Owing to the timing of the one-off costs related to the business
change projects, reported profits for the second half of the year to 25
January 2025 are expected to be higher than those for the 26 weeks ended 27
July 2024.
8. Operating profit
The following items have been charged/(credited) to operating profit during
the period:
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
£m £m £m
Business change projects 4.4 - -
Provision for business reorganisation 0.7 - -
(Gain)/loss on sale of property, plant and equipment (0.1) 0.1 -
Included within the business change project costs is a £1.1m impairment
charge against assets classified as held for sale (Note 13).
9. Net finance costs
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
Finance income £m £m £m
Interest receivable on short-term deposits 0.7 0.6 1.3
Finance costs relating to defined benefit pension plans 0.1 0.1 0.1
0.8 0.7 1.4
Finance costs £m £m £m
Interest payable 0.1 - 0.1
Lease interest 0.1 0.1 0.1
0.2 0.1 0.2
10. Tax on profit
The interim period total tax charge of £6.2m (six months ended 30 July 2023:
£6.8m; year ended 28 January 2024: £12.8m) is accrued based on the estimated
annual effective tax rate of 24.9% (six months ended 30 July 2023: 24.5%; year
ended 28 January 2024: 25.0%). The effective tax rate is calculated using the
forecast year end effective corporation tax rate and the movement in deferred
tax to 27 July 2024. The effective tax rate has remained relatively unchanged
in the six months ended 27 July 2024 compared to the year ended 28 January
2024.
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
Analysis of tax charge £m £m £m
Current income tax charge 5.3 6.4 11.7
Deferred income tax charge 0.9 0.4 1.1
Total tax charge in the condensed income statement 6.2 6.8 12.8
11. Earnings per share
Basic earnings per share has been calculated by dividing the earnings
attributable to equity holders of the parent by the weighted average number of
shares in issue during the year, excluding shares held by the employee share
scheme trusts.
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
Profit attributable to equity holders of the Company (£m) 18.7 21.0 38.5
Weighted average number of ordinary shares in issue 110,797,643 111,288,517 111,289,068
Basic earnings per share (pence) 16.88 18.87 34.59
For diluted earnings per share, the weighted average number of ordinary shares
in issue is adjusted to assume conversion of all potentially dilutive ordinary
shares. These represent share options granted to employees where the exercise
price is less than the average market price of the Company's ordinary shares
during the period. The number of shares calculated as above is compared with
the number of shares that would have been issued assuming the exercise of the
share options.
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
Profit attributable to equity holders of the Company (£m) 18.7 21.0 38.5
Weighted average number of ordinary shares in issue 110,797,643 111,288,517 111,289,068
Adjustment for dilutive effect of share options 1,047,922 1,193,573 1,159,537
Diluted weighted average number of ordinary shares in issue 111,845,565 112,482,090 112,448,605
Diluted earnings per share (pence) 16.72 18.67 34.24
12. Dividends
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024 Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
per share (p) per share (p) per share (p) £m £m £m
Paid final dividend 12.4 10.60 10.60 13.8 11.8 11.8
Paid interim dividend - - 2.65 - - 2.9
12.40 10.60 13.25 13.8 11.8 14.7
An interim dividend of 3.10 pence per share was approved by the Board on 24
September 2024 and will be paid on 1 November 2024 to shareholders on the
register as of 4 October 2024.
13. Assets classified as held for sale
Unaudited £m
Balance at 29 January 2023 and 28 January 2024 -
Net book value of assets transferred from property, plant and equipment 3.2
Impairment charge (1.1)
Balance at 27 July 2024 2.1
The closure of the Barr Direct business resulted in a number of vehicles on
the balance sheet with no estimated useful life. Following an assessment of
fair value less costs to sell an impairment charge of £1.1m has been
recognised. These assets are being actively marketed and a number have been
sold since the period end.
14. Financial instruments
Current liabilities of £0.5m (at 30 July 2023 and 28 January 2024: £0.3m)
relate to forward foreign currency contracts with a maturity of less than 12
months and are recognised at fair value through the cash flow hedge reserve,
included within other reserves.
Non-current liabilities of £0.1m (at 30 July 2023 and 28 January 2024: £nil)
relate to forward foreign currency contracts with a maturity of more than 12
months and are recognised at fair value through the cash flow hedge reserve,
included within other reserves.
Fair value hierarchy
Fair value hierarchies 1 to 3 are based on the degree to which fair value is
observable:
Level 1: quoted prices (unadjusted) in active markets for identical assets or
liabilities
Level 2: inputs other than quoted prices included within Level 1 that are
observable for the asset or liability, either directly (i.e. as prices) or
indirectly (i.e. derived from prices)
Level 3: inputs for the asset or liability that are not based on observable
market data
The fair value of financial instruments that are not traded in an active
market (for example, over-the-counter derivatives) is determined by using
valuation techniques. These valuation techniques maximise the use of
observable market data where it is available and rely as little as possible on
entity specific estimates. The fair value of the forward foreign exchange
contracts is determined using forward exchange rates at the date of the
consolidated condensed statement of financial position, with the resulting
value discounted accordingly as relevant.
All financial instruments carried at fair value are Level 2.
Fair values of financial assets and financial liabilities
The following table shows the carrying amounts and fair values of financial
assets and financial liabilities. It does not include fair value information
for financial assets and financial liabilities not measured at fair value if
the carrying amount is a reasonable approximation of fair value.
Carrying amount
Unaudited Fair value - hedging instruments Other financial assets at amortised cost Other financial liabilities at amortised cost Total
At 27 July 2024 £m £m £m £m
Financial assets - Current
Foreign exchange contracts used for hedging - - - -
Trade receivables - 91.2 - 91.2
Short-term investments - 32.5 - 32.5
Cash and cash equivalents - 17.3 - 17.3
- 141.0 - 141.0
Financial liabilities - Non-current
Foreign exchange contracts used for hedging 0.1 - - 0.1
Lease liabilities - - 2.6 2.6
0.1 - 2.6 2.7
Financial liabilities - Current
Bank overdraft - - 6.1 6.1
Foreign exchange contracts used for hedging 0.5 - - 0.5
Lease liabilities - - 1.7 1.7
Accruals - - 37.0 37.0
Trade payables - - 42.6 42.6
0.5 - 87.4 87.9
Carrying amount
Unaudited Fair value - hedging instruments Other financial assets at amortised cost Other financial liabilities at amortised cost Total
At 30 July 2023 £m £m £m £m
Financial assets - Current
Foreign exchange contracts used for hedging - - - -
Trade receivables - 93.9 - 93.9
Cash and cash equivalents - 47.3 - 47.3
- 141.2 - 141.2
Financial liabilities - Non-current
Lease liabilities - - 3.2 3.2
- - 3.2 3.2
Financial liabilities - Current
Foreign exchange contracts used for hedging 0.3 - - 0.3
Lease liabilities - - 1.6 1.6
Trade payables - - 90.7 90.7
0.3 - 92.3 92.6
Carrying amount
Audited Fair value - hedging instruments Other financial assets at amortised cost Other financial liabilities at amortised cost Total
At 28 January 2024 £m £m £m £m
Financial assets - Current
Trade receivables - 59.8 - 59.8
Short-term investments - 20.0 - 20.0
Cash and cash equivalents - 33.6 - 33.6
- 113.4 - 113.4
Financial liabilities - Non-current
Lease liabilities - - 3.1 3.1
- - 3.1 3.1
Financial liabilities - Current
Foreign exchange contracts used for hedging 0.3 - - 0.3
Lease liabilities - - 1.8 1.8
Accruals - - 30.0 30.0
Trade payables - - 36.1 36.1
0.3 - 67.9 68.2
15. Loans and other borrowings
Movements in borrowings are analysed as follows:
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
£m £m £m
Opening borrowings balance 4.9 5.8 5.8
Net lease movements (0.6) (0.3) (0.2)
Borrowings acquired/drawn-down 6.1 5.0 5.0
Repayments of borrowings - (5.7) (5.7)
Closing borrowings balance 10.4 4.8 4.9
The reconciliation of the above closing borrowings balance to the figures on
the face of the consolidated condensed statement of financial position is as
follows:
Unaudited Unaudited Audited
As at 27 July 2024 As at 30 July 2023 As at 28 January 2024
£m £m £m
Bank borrowings 6.1 - -
Lease liabilities 4.3 4.8 4.9
Total borrowings and loans 10.4 4.8 4.9
Disclosed as:
Current liabilities 7.8 1.6 1.8
Non-current liabilities 2.6 3.2 3.1
The reconciliation to net debt is as follows:
Unaudited Unaudited Audited
As at 27 July 2024 As at 30 July 2023 As at 28 January 2024
£m £m £m
Closing borrowings balance (10.4) (4.8) (4.9)
Short-term investments 32.5 - 20.0
Cash and cash equivalents 17.3 47.3 33.6
Net funds 39.4 42.5 48.7
In July 2024, the Group agreed a £15m overdraft facility with the Royal Bank
of Scotland. This will support intra-month working capital requirements and
maximise cash deposit interest.
The drawn/undrawn facilities at 27 July 2024 are as follows:
Total facility Drawn Undrawn
£m £m £m
Revolving credit facility - five years, expires February 2026 20.0 - 20.0
Overdraft facility 15.0 6.1 8.9
35.0 6.1 28.9
16. Provisions
Business change projects Business reorganisation Customer related provisions Repairs/ Total
Dilapidations
Unaudited £m £m £m £m £m
Opening provision at 29 January 2023 - 0.3 0.1 0.4 0.8
Provision utilised during the year - (0.3) - - (0.3)
Closing provision at 28 January 2024 - - 0.1 0.4 0.5
Provision created during the year 3.3 0.7 - - 4.0
Provision utilised during the year (2.5) - - - (2.5)
Closing provision at 27 July 2024 0.8 0.7 0.1 0.4 2.0
The business change projects provision relates to the costs associated with
two projects. Firstly, the closure of the Barr Direct operation and the move
to larger field sales team, supplying brands through existing wholesale
channels which completed in June. Secondly, the integration of the Boost
business into Barr Soft Drinks. This will result in a reduction in duplicated
activities and access to the wider Barr Soft Drinks sales channels and
organisation and also the closure of the Boost Leeds office. This is expected
to complete by the end of the year ending 25 January 2025.
The business reorganisation provision relates to costs associated with a
number of smaller business reorganisations not related to the business change
projects.
The customer related provision relates to costs for chiller and vendor
disposal and the repairs and dilapidation provision relates to costs provided
to make good leased properties on exit.
17. Retirement benefit obligations
On 1 May 2016 the A.G. BARR p.l.c. (2008) Pension and Life Assurance Scheme
was closed to future accrual following a negotiated agreement between the
Company and the board of trustees.
The defined retirement benefit scheme had a surplus of £6.2m as at 27 July
2024 (surplus as at 30 July 2023: £3.2m; surplus as at 28 January 2024:
£3.2m). The reconciliation of the closing surplus is as follows:
Unaudited Unaudited Audited
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
£m £m £m
Opening present value of obligation (69.3) (76.9) (76.9)
Interest expense (1.6) (1.6) (3.3)
Remeasurement - changes in financial assumptions (0.5) 6.2 6.7
Benefits paid 1.7 1.9 4.2
Closing present value of obligation (69.7) (70.4) (69.3)
Opening fair value of plan assets 72.5 79.3 79.3
Interest income 1.7 1.7 3.4
Remeasurement - actuarial return on assets 0.5 (5.5) (6.0)
Employer contributions 2.9 - -
Benefits paid (1.7) (1.9) (4.2)
Closing fair value of plan assets 75.9 73.6 72.5
As at 27 July 2024 As at 30 July 2023 As at 28 January 2024
£m £m £m
Present value of funded obligations (69.7) (70.4) (69.3)
Fair value of plan assets 75.9 73.6 72.5
Surplus recognised under IAS 19 6.2 3.2 3.2
The key financial assumptions used to value the liabilities were as follows:
As at 27 July 2024 As at 30 July 2023 As at 28 January 2024
% % %
Discount rate 5.1 5.2 5.0
Inflation assumption 3.2 3.2 3.1
18. Movements in own shares held by employee benefit trusts
During the six months to 27 July 2024 the employee benefit trusts of the Group
acquired 338,003 (six months to 30 July 2023: 520,218; year to 28 January
2024: 732,524) of the Company's shares. The total amount paid to acquire the
shares has been deducted from shareholders' equity and is included within
retained earnings. At 27 July 2024 the shares held by the Company's employee
benefit trusts represented 793,306 (30 July 2023: 1,187,730; 28 January 2024:
1,048,677) shares at a purchased cost of £4.1m (30 July 2023: £6.6m; 28
January 2024: £5.4m).
593,778 (six months to 30 July 2023: 220,041; year to 28 January 2024:
571,410) shares were utilised in satisfying share options from the Company's
employee share schemes during the same period. The related weighted average
share price at the time of exercise for the six months to 27 July 2024 was
£6.00 (six months to 30 July 2023: £4.66; year to 28 January 2024: £4.78).
19. Contingencies and commitments
Unaudited Unaudited Audited
As at 27 July 2024 As at 30 July 2023 As at 28 January 2024
£m £m £m
Commitments for the acquisition of property, plant and equipment 2.5 7.7 8.7
20. Related party transactions
There have been no related party transactions in the first 26 weeks of the
current financial year which have materially affected the financial position
or performance of the Group.
RESPONSIBILITY AND CAUTIONARY STATEMENTS
Responsibility Statement
Company law requires the directors to prepare statements for each financial
year. Under that law the directors are required to prepare group financial
statements in accordance with international accounting standards in conformity
with the requirements of the Companies Act 2006 and UK-adopted International
Financial Reporting Standards.
The directors confirm that these consolidated condensed interim financial
statements have been prepared in accordance with International Accounting
Standard 34 Interim Financial Reporting. The interim management report
includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8,
namely:
• an indication of important events that have occurred during the first six
months and their impact on the condensed set of financial statements, and a
description of the principal risks and uncertainties for the remaining six
months of the financial year; and
• material related party transactions in the first six months and any
material changes in the related party transactions described in the last
annual report.
Cautionary Statement
This report is addressed to the shareholders of A.G. BARR p.l.c. and has been
prepared solely to provide information to them.
This report is intended to inform the shareholders of the Group's performance
during the six months to 27 July 2024. This report contains forward-looking
statements based on knowledge and information available to the directors as at
the date the report was prepared. These statements should be treated with
caution due to the inherent uncertainties underlying any such forward-looking
information and any statements about the future outlook may be influenced by
factors that could cause actual outcomes and results to be materially
different.
The directors of A.G. BARR p.l.c. that served during the six months to 27 July
2024 and up to the date of signing, and their respective responsibilities,
were:
Mark Allen OBE (Chair)
Roger A. White (Chief Executive) (resigned 30 April 2024)
Euan Sutherland (Chief Executive) (appointed 1 May 2024)
Stuart Lorimer (Finance Director)
Jonathan D. Kemp (Commercial Director) (resigned 31 May 2024)
Susan V. Barratt
Zoe L. Howorth
David J. Ritchie (resigned 31 May 2024)
Nicholas B.E. Wharton
Julie A. Barr
Louise H. Smalley
For and on behalf of the Board of Directors
Euan Sutherland Stuart Lorimer
Chief Executive Finance Director
24 September 2024 24 September 2024
Glossary
Non-GAAP measures are provided because they are tracked by management to
assess the Group's operating performance and to inform financial, strategic
and operating decisions.
Adjusting items
The Group excludes adjusting items from its non-GAAP measures because of their
size, frequency and nature to allow shareholders to understand better the
elements of financial performance in the period, so as to facilitate
comparison with prior periods and to assess trends in financial performance
more readily. These items are primarily non-operational.
Definitions of non-GAAP measures used are provided below:
Capital expenditure is a non-GAAP measure and is defined as the cash purchases
of property, plant and equipment and is disclosed in the consolidated
condensed cash flow statement.
Adjusted profit attributable to equity holders is a non-GAAP measure
calculated as adjusted profit attributable to equity holders.
Operating margin (adjusted) is a non-GAAP measure calculated by dividing
adjusted operating profit by revenue.
Profit before tax (adjusted) is a non-GAAP measure calculated as reported
profit before tax after adjusting items.
Basic EPS (adjusted) is a non-GAAP measure calculated by dividing adjusted
profit attributable to equity holders by the weighted average number of shares
in issue.
Reconciliation of Non-GAAP measures
Adjusted Consolidated Income Statements
Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
Reported Business change projects Adjusted Reported Boost earn-out accrual write back Adjusted Reported Boost earn-out accrual write back Adjusted
£m £m £m £m £m £m £m £m £m
Revenue 221.3 - 221.3 210.4 - 210.4 400.0 - 400.0
Cost of sales (132.2) - (132.2) (131.0) - (131.0) (245.8) - (245.8)
Gross profit 89.1 - 89.1 79.4 - 79.4 154.2 - 154.2
Operating expenses (64.8) 4.4 (60.4) (52.2) (0.8) (53.0) (104.1) (0.8) (104.9)
Operating profit 24.3 4.4 28.7 27.2 (0.8) 26.4 50.1 (0.8) 49.3
Finance income 0.8 - 0.8 0.7 - 0.7 1.4 - 1.4
Finance costs (0.2) - (0.2) (0.1) - (0.1) (0.2) - (0.2)
Profit before tax 24.9 4.4 29.3 27.8 (0.8) 27.0 51.3 (0.8) 50.5
Tax on profit (6.2) (1.1) (7.3) (6.8) - (6.8) (12.8) - (12.8)
Profit for the period 18.7 3.3 22.0 21.0 (0.8) 20.2 38.5 (0.8) 37.7
Adjusting entries:
Business change projects - the costs associated with the business change
projects involving the closure of Barr Direct operations and the integration
of the Boost business.
Boost earn-out reversal - certain conditions associated with the Boost
earn-out were not met and as such the earn-out was not be payable in its
previous form but was incorporated into employee reward incentives.
Operating margin (adjusted) Six months ended 27 July 2024 Six months ended 30 July 2023 Year ended 28 January 2024
£m £m £m
Revenue 221.3 210.4 400.0
Adjusted operating profit 28.7 26.4 49.3
Operating margin (adjusted) 13.0% 12.5% 12.3%
Net cash at bank £m £m £m
Cash and cash equivalents 17.3 47.3 33.6
Short-term investments 32.5 - 20.0
Bank overdraft (6.1) - -
Net cash at bank 43.7 47.3 53.6
Basic EPS (adjusted)
Adjusted profit attributable to equity shareholders of the Company £m 22.0 20.2 37.7
Weighted average number of ordinary shares in issue 110,797,643 111,288,517 111,289,068
Basic EPS (adjusted) 19.86p 18.15p 33.88p
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IR EAXNDASALEFARecent news on A G Barr
See all newsREG - Barr(A.G.) PLC - Potential disposal of Strathmore Business
AnnouncementREG - Barr(A.G.) PLC - Director/PDMR Shareholding
AnnouncementREG - Barr(A.G.) PLC - Director/PDMR Shareholding
AnnouncementREG - Barr(A.G.) PLC - Annual Financial Report
AnnouncementREG - Barr(A.G.) PLC - Director/PDMR Shareholding
Announcement